Everyone Healthy Library
Abetalipoproteinemia
Also Known As: Abetalipoproteinemia neuropathy
Condition / disease reference page from the Everyone Healthy database.
Connected health information
Explore this condition in a clear order
Condition overview
Attributes
Linked signs and symptoms
11Each sign/symptom opens its own page and links back to related conditions.
- Diarrhoea (Diarrhea)
- Eye Vision Deficit in Dim Lighting
- Fatigue
- Mind: Developmental Delay
- Movement: Muscle Coordination Loss (Ataxia)
- Muscle Reflexes Below Normal (Hyporeflexia)
- Muscle Weakness
- Skin: Pale, Lack of Colour (Pallid Complexion)
- Speech Articulation Problem (Dysarthria)
- Voluntary Withering (Intention Tremor)
- Weight Loss (Body Mass Index Decreased)
Linked drugs / medications
0No linked drugs are listed yet.
Treatments, therapies and supportive options
4Grouped by treatment type. These are educational database links, not personal treatment recommendations. Evidence labels are shown only where stored in the EH database.
Alternative medicine
1Vitamins and minerals
2Linked diagnostic tests and investigations
7These are pulled from both EH diagnostic-test link tables, including the older large test-link table.
Biological and test markers
3This visual map uses existing EH database links to show biological agents and lab markers reported as increased, decreased, or associated with this condition. These are educational relationships only; test results must be interpreted by a qualified clinician because ranges vary by lab, method, age, sex and clinical context.
Often increased
1Often decreased
2- Anion Gap (Including Potassium)Reference range exampleAll: 12–20 mEq/LLinked diagnostic tests1Anion Gap
- TriglyceridesReference range exampleAdult ( > 16y), Female: 32–137 mg/dL; Adult ( > 16y), Male: 35–155 mg/dLLinked diagnostic tests2Triglyceride (TG's) Concentration, Triglyceride (TGs) Concentration
Other associated markers
0No markers in this group.
Introduction / full article
Abetalipoproteinemia
Abetalipoproteinemia
Vitamin E Supplement High Dosage [1, 2 ]
REcommendation: Strongly in favour
Level of Evidence: Moderate level of evidence
Abetalipoproteinemia (also known as Bassen-Kornzweig syndrome) is a recessive disorder that impedes the digestion of dietary fats, cholesterol and fat-soluble vitamins. Patients affected by the condition are unable to produce certain lipoproteins and fats, leading to deficiencies of the fat-soluble vitamins A, D, E and K.
Causes
This disorder is linked to a mutation in the microsomal triglyceride transfer protein (MTTP) gene, which provides instructions for the production of a protein imperative to the creation of lipoproteins. These lipoproteins are, in turn, essential for the absorption of fats, cholesterol and fat-soluble vitamins from food, and the transport of these nutrients to the bloodstream.
Symptoms and diagnosis
The symptoms of abetalipoproteinemia appear in early childhood, and will indicate that the body is not making or absorbing the nutrients that it requires. These include:
· Failure to gain weight and grow in infancy;
· Pale, foul-smelling, fatty stools; and
· Presence of fat and/or blood in stools.
Other symptoms will result from a severe vitamin deficiency, such as:
· Poor muscle coordination;
· Degeneration of the retina, leading to near-blindness;
· Developmental delay or mental retardation; and
· Scoliosis (curvature) of the spine.
Abetalipoproteinemia can be clinically diagnosed by the analysis and subsequent detection of fat in foul-smelling stools. Similarly, a deficiency of the affected nutrients in the bloodstream can also be used as an indicator.
Treatment
Treatment for abetalipoproteinemia typically involves a controlled diet including high levels of vitamin E. This helps the body to produce and restore other missing nutrients, such lipoproteins.
Conditions arising from vitamin deficiency, for example muscle weakness and poor coordination, can be remedied with physiotherapy and/or occupational therapy.
References.
1. https://rarediseases.org/rare-diseases/abetalipoproteinemia/
2. http://emedicine.medscape.com/article/121975-treatment